Inhaltsseite: Home

ZKB Mini-Future Long auf Novo Nordisk -B-, Open End
Novo Nordisk A/S

ISIN: CH1338510493 Security: 133851049 Symbol: INOFXZ Life cycle
redeemed

Bid Price n.a.

Ask Price n.a.

Currency n.a.

Exchange SIX Structured Products

Volume n.a.

Volume n.a.

Date/time (delayed) n.a. n.a.

Sell Buy 

Product Download

Security PDF for download Publication date
Termsheet 17.07.2024
Key Information Document DE 17.07.2024
Key Information Document EN 17.07.2024
Key Information Document FR 17.07.2024
Key Information Document IT 17.07.2024

Price data

  Bid Ask
Price n.a. n.a.
Volume n.a. n.a.
Date/time n.a. n.a. n.a. n.a.

Current data

Last price paid n.a.
Change -2.13% [ -0.01 ]
Last traded volume n.a. Unit
Cumulative volume n.a. Unit
Date/time n.a. n.a.

Life cycle

Fixingn.a.
Settlement date18.06.2024
Last tradingn.a.
Final fixingn.a.
Currency redemptionCHF

Performance

Perf. since issue -10.78%
Year to date (YTD) n.a.
1 month n.a.
3 months n.a.
1 year n.a.
3 years n.a.

Key figures on issue

Issue price0.51
Underlying price on issue982.10
Premium0.01%
Premium p.a.n.a.
Leveragen.a.
Implied volatilityn.a.

Reference data

ISIN CH1338510493
Symbol INOFXZ
Security 133851049
Exchange SIX Structured Products
Currency CHF
Expiry n.a.
Underlying Novo Nordisk -B-, DK0062498333
Underlying ISIN DK0062498333
Funding level 889.933700
Stop-loss level 922.492900
Distance to stop-loss level 4.90%
Long/Short type Long
Subscription ratio 25.00
Issuer Zürcher Kantonalbank
Exercise type n.a.
Minimum execution n.a.
Value day 14.06.2024

Key figures

Premium 0.70%
Premium p.a. n.a.
Leverage 11.14
Moneyness in-the-money
Leverage n.a.
Delta n.a.
Intrinsic value 80.248500
Break-even n.a.
SSPA value at risk n.a.
SSPA risk rating n.a.

Product type

SSPA derivative category Leverage
SSPA code Mini future (2210)

Early redemption

Redemption date 24.07.2024
Redemption amount 0.17

Ajax loading